Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ivermectin B1a aglycone is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 784.00 | |
5 mg | 35 days | $ 3,180.00 |
Description | Ivermectin B1a aglycone is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. |
Molecular Weight | 586.766 |
Formula | C34H50O8 |
CAS No. | 73162-95-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methanol: Soluble
DMSO: Soluble
DMF: Soluble
Ethanol: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ivermectin B1a aglycone 73162-95-5 Ivermectin B-1a aglycone inhibitor inhibit